Please login to the form below
Moderna
This page shows the latest Moderna news and features for those working in and with pharma, biotech and healthcare.
Moderna files record $500m IPO for RNA pipeline
Moderna files record $500m IPO for RNA pipeline. Could be the largest IPO for a biotech start-up. ... Moderna Therapeutics, a specialist in messenger RNA-based drugs, has filed a $500m initial public offering (IPO) that would break all records for a
Latest news
-
Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab's OX40 candidate
RNA drug specialist Moderna also have their own OX40L candidate, mRNA-2416 in early stage trials.
-
AZ makes gene therapy move with 4DMT alliance
It also has a long-running collaboration with Moderna seeking messenger RNA drugs for the treatment of cardiovascular, metabolic and renal diseases as well as selected targets in oncology, and is
-
Morning brief: New biotech launched, Merck and Moderna expand collaboration and more
A rapid round up of pharma, biotech and healthcare news. Merck and Moderna expand cancer vaccines work. ... The two companies have now added to their collaboration shared antigen mRNA cancer vaccines including mRNA-5671, Moderna’s mRNA KRAS cancer
-
BMS to explore new options for its immuno-oncology drug Opdivo
Like BMS, Merck &Co has also moved to extend the reach of its immuno-oncology drug, teaming up with Moderna Therapeutics to develop personalised cancer vaccines that would work alongside Keytruda.
-
Merck & Co signs cancer vaccines research deal for Keytruda
The deal with Moderna Therapeutics will see it use the Cambridge, Massachusetts-based company's novel messenger RNA (mRNA)-based vaccine technology. ... Moderna's mRNA vaccine technology uses the unique mutations present in a patient's tumour to provoke
More from news
Approximately 4 fully matching, plus 12 partially matching documents found.
Latest Intelligence
-
Deal Watch September 2016
Deal Watch September 2016. Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up. ... up. Turning to the battle against the Zika virus, BARDA announced three more grants for vaccine development to Takeda (up
-
Deal Watch June 2016
Apart from the $200m upfront cash payment to Moderna, there were no other financials disclosed. ... licence. 230. Moderna Therapeutics/ Merck &Co. mRNA-based personalised cancer vaccines; exclusive for Keytruda combinations (discovery).
-
Deal Watch October 2015
Whilst considering nucleic acid-based approaches, it was interesting to see that mRNA company Moderna Therapeutics, which has a number of deals under its belt with AstraZeneca, Alexion and Merck &Co, ... This is Moderna's fourth venture in what it calls
-
Deal Watch table for January 2014
144. Moderna Therapeutics/ Alexion Pharmaceuticals. Exclusive discovery and development. Messenger RNA (mRNA) therapeutics in rare diseases for 10 product options.
-
Deal Watch table for October 2013
Moderna Therapeutics / DARPA. R&D grant. mRNA therapeutics for biodefence targets (discovery).
More from intelligence
Approximately 1 fully matching, plus 6 partially matching documents found.
Latest appointments
-
Tony de Fougerolles joins Evox Therapeutics as CEO
Prior to this, he was chief scientific officer at Moderna Therapeutics and has held the same role at Tolerx.
-
Medicxi appoints former GSK chair Moncef Slaoui
Dr Slaoui takes on the role alongside his other board positions, which include chairman of the board at Galvani Bioelectronics, and on the boards of Artisan Biosciences, Moderna Therapeutics and Sutovax.
-
MIT chief financial officer joins Moderna Therapeutics
MIT chief financial officer joins Moderna Therapeutics. Israel Ruiz to serve as audit committee chair on its board of directors. ... US-based biotech Moderna Therapeutics has appointed Israel Ruiz to its board of directors to serve as audit committee
-
PureTech Health appoints chief scientific officer
Bringing over 30 years of clinical development experience to the role, he joins from Moderna Therapeutics where he most recently served as president and chief scientific officer.
-
Dr Michael Watson appointed as president of Valera
Dr Michael Watson appointed as president of Valera. Former Sanofi Pasteur policy head joins Moderna Therapeutics firm. ... Valera, one of Moderna Therapeutics' venture companies, has appointed Dr Michael Watson as its new president.
More from appointments
Approximately 3 fully matching, plus 5 partially matching documents found.
Featured jobs
-
Account Manager / Account Director
-
Competative
- Senior Account Executive, London, Medical Communications
-
Excellent package
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
New Business Director - PR
-
Competitive Salary and benefits
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Senior Medical Writer
-
Competitive Salary
-
Senior Medical Writer
-
Great salary and benefits
-
Associate Director
-
£75, 000-90, 000
-
Associate Medical Director
-
Highly Competitive
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
Subscribe to our email news alerts
- Spectral Computed Tomography (CT) Market Global Briefing and Future Outlook 2018 to 2023
- Wearable Heart Monitoring Device Market to Witness Robust Expansion Throughout the Forecast Period 2018 to 2023
- Snoring Control Device Market Global Briefing and Future Outlook 2018 to 2023
- Smart Wellness Market Global Research Analysis 2018 to 2023
- Zinc Lactate Market Overview, Growth Forecast, Demand and Development Research Report to 2023
- Zinc Gluconate Market to Witness Growth Acceleration During 2018-2023
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
